The $10.5M Accutane verdict in Kendall v. Roche has been reversed, and remanded for retrial, for reasons similar to last year's reversal of McCarrell v. Roche.
0 Comments Click here to read/write comments
Topics: Toxic Torts, Kendall v. Roche, Products Liability, accutane, Pharmaceutical
UPDATE: Because of the Appellate Division's decision in Kendall v. Roche, The Greenblatt case has been continued with no new date. However, the case is expected to come back on calendar.
UPDATE 2: The Greenblatt trial is now scheduled to begin February 14, 2011. Watch it on live CVN.
0 Comments Click here to read/write comments
Topics: Toxic Torts, Products Liability, accutane, Greenblatt v. Roche, Pharmaceutical
The jury in Chanin v. Desert Shadow Endoscopy today awarded $500M in punitive damages against Baxter and Teva -- $144M against Baxter and $356M against Teva -- the pharmaceutical companies that manufactured (Teva) and distributed (Baxter) vials of the anesthetic Propofol.
0 Comments Click here to read/write comments
Topics: Toxic Torts, Products Liability, Endoscopy Center Cases, Pharmaceutical
0 Comments Click here to read/write comments
Topics: Toxic Torts, Products Liability, Endoscopy Center Cases, Pharmaceutical
Defense fired back in their opening statement in Chanin v. Desert Shadow Endoscopy Center. The plaintiffs alleged that drug companies Baxter and Teva supplied propofol containers that were defective because they were too large, thus encouraging the kind of multi-dose "double-dipping" that could foreseeably result in the spread of blood-born pathogens, such as the Hepatitis C infection that plaintiff Henry Chanin contracted at Desert Shadow Endoscopy.
0 Comments Click here to read/write comments
Topics: Toxic Torts, Products Liability, Endoscopy Center Cases, Pharmaceutical
